Discover
ORIC
ORIC Pharmaceuticals, Inc.
11.99
2 x 8.83
2 x 15.36
bid
ask
-
0.04
0.33%
2 @ 04:01 PM
11.99 +0.00 (0.00%)
| Ytd | 46.58% | |
| 1y | -14.84% |
11.90
day range
12.29
7.47
52 week range
14.65
| Open | 11.98 | Prev Close | 12.03 | Low | 11.90 | High | 12.29 | Mkt Cap | 1.24B |
| Vol | 1.09M | Avg Vol | 1.48M | EPS | -1.32 | P/E | N/A | Forward P/E | -7.17 |
| Beta | 0.98 | Short Ratio | 15.02 | Inst. Own | 123.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 12.99 | 200-d Avg | 10.91 | 1yr Est | 21.43 |
| Income Statement | |||
| Operating Expenses | 45.30M | ||
| Research and Development Expense | 36.30M | ||
| Selling, General and Administrative Expense | 9.00M | ||
| Operating Income | -45.30M | ||
| Net Income | -41.49M | ||
| Net Income Common Stock | -41.49M | ||
| Net Income Common Stock (USD) | -41.49M | ||
| Consolidated Income | -41.49M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -41.49M | ||
| Earning Before Interest & Taxes (USD) | -41.49M | ||
| Weighted Average Shares | 108.01M | ||
| Weighted Average Shares Diluted | 108.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 37.48M | ||
| Cash and Equivalents (USD) | 37.48M | ||
| Investments | 350.08M | ||
| Investments Current | 227.28M | ||
| Investments Non-Current | 122.80M | ||
| Current Assets | 273.70M | ||
| Property, Plant & Equipment Net | 2.24M | ||
| Total Assets | 404.69M | ||
| Current Liabilities | 20.76M | ||
| Total Liabilities | 23.43M | ||
| Accumulated Retained Earnings (Deficit) | -769.50M | ||
| Accumulated Other Comprehensive Income | -1.02M | ||
| Shareholders Equity | 381.26M | ||
| Shareholders Equity (USD) | 381.26M | ||
| Assets Non-Current | 130.99M | ||
| Liabilities Non-Current | 2.67M | ||
| Trade and Non-Trade Payables | 3.87M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 264.00K | ||
| Net Cash Flow from Financing | 828.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -18.91M | ||
| Capital Expenditure | -356.00K | ||
| Issuance (Purchase) of Equity Shares | 828.00K | ||
| Net Cash Flow from Investing | 11.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 12.22M | ||
| Net Cash Flow from Operations | -31.60M | ||
| Share Based Compensation | 7.09M | ||